Zhaoke Ophthalmology Company Description

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong.

It is developing various drugs that cover ophthalmic indications, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma.

The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People’s Republic of China.

Zhaoke Ophthalmology Limited

Country	Cayman Islands
Founded	2017
Industry	Biotechnology
Sector	Healthcare
Employees	294
CEO	Xiaoyi Li

Contact Details

Address: No. 1 Meide 3rd Road Guangzhou China
Phone	86 20 3906 2828
Website	zkoph.com

Stock Details

Ticker Symbol	6622
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	KYG989M51017
SIC Code	2834

Key Executives

Name	Position
Dr. Xiaoyi Li Ph.D.	Chief Executive Officer and Executive Chairman of the Board
Xiangrong Dai	Chief Operating Officer and Executive Director
Dr. Lit Fui Lau	President and Chief Scientific Officer
Yang Lei	Group General Counsel
Dr. Mauro Bove Ph.D.	Senior Vice President of Corporate Development
Jiang Feng	Senior Vice President of Sales and Marketing
Dr. Albert Tsai Jr.	Chief Medical Officer
Guohui Zhang	Senior Vice President of Manufacturing and Logistics
Carol Liu	Group Head of Regulatory Affairs
Suk Yan Yau CPA	Vice President of Financial Dept. and Company Secretary